Blog Archives

NEW YORK, NY (September 1, 2023) — Hemali Phatnani, PhD, Director of the Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center and Assistant Professor at Columbia University, spoke with Target ALS about her involvement with the foundation since its inception, and how their funding has shaped her research experience. “Target […]

NEW YORK, NY (August 18, 2023) — Researchers at the New York Genome Center (NYGC) are collaborating under a recent grant from Target ALS, a medical research foundation committed to the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS). Hemali Phatnani, PhD, Core Faculty Member and Director of the Center for Genomics of Neurodegenerative […]